Unicycive Therapeutics Files 8-K on Shareholder Votes & Financials
Ticker: UNCY · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1766140
| Field | Detail |
|---|---|
| Company | Unicycive Therapeutics, Inc. (UNCY) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
Unicycive filed an 8-K for shareholder votes and financials. Keep an eye on this.
AI Summary
On June 9, 2025, Unicycive Therapeutics, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The company, incorporated in Delaware with its principal executive offices in Los Altos, CA, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing indicates important corporate actions and financial reporting, which are crucial for investors to understand the company's governance and financial health.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Numbers
- 001-40582 — SEC File Number (Identifies the company's filing with the SEC.)
- 81-3638692 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Unicycive Therapeutics, Inc. (company) — Registrant
- June 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Los Altos, CA (location) — Address of principal executive offices
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What financial statements are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in the provided text.
When was Unicycive Therapeutics, Inc. incorporated?
Unicycive Therapeutics, Inc. was incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive offices are located at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
What is the SIC code for Unicycive Therapeutics, Inc.?
The Standard Industrial Classification code for Unicycive Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Unicycive Therapeutics, Inc. (UNCY).